Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Unknown 6Recruiting 5Not yet recruiting 3Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Motor Activity 1Fatigue 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Rehabilitation × Clear all
NCT05017597 2023-09-08

Online Cancer-Related Fatigue Management

Eastern Kentucky University

Phase NA Withdrawn

Fatigue, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡